Company: INTS
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001567264-25-000103
Chunk: 62

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 62
---
 months ended September 30, 2025 and 2024, a dividend yield of 0% was used because the Company has not historically paid and does not intend to pay a dividend on common stock in the foreseeable future. The expected stock price volatility assumption was estimated based on the historical volatilities for industry peers, as the Company had no active market for its stock prior to the IPO and limited history for issuance price of its stock. The risk-free rate assumption is determined using the yield currently available on U.S. Treasury zero coupon issues with a remaining term commensurate with the expected term of the award. The expected term of the option represents the period the options are expected to be outstanding.The following table summarizes the activity for stock options under the 2013 and 2021 Plans for the nine months ended September 30, 2025:OptionsWeighted-Average Exercise PriceWeighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)Outstanding at December 31, 20242,587,129 $6.14 7.9$— Issued1,505,000 $0.57 Exercised— $— Forfeited and cancelled(81,328)$3.71 Outstanding at September 30, 20254,010,801 $4.10 8.1$— Exercisable at September 30, 20251,786,963 $6.15 6.8$— All options expire 10 years from date of grant. Options outstanding begin to expire in June 2026. Options that were granted to employees and consultants have vesting periods that vary by award to recipient and range from immediate vesting to a period of up to 4 years.As of September 30, 2025, total unrecognized compensation cost related to options was approximately $3.2 million and is expected to be recognized over the remaining weighted average service period of 2.3 years.

10

WarrantsThe following table summarizes the range of assumptions used to estimate the fair value of warrants issued using the Black-Scholes-Merton option pricing model:Nine Months Ended September 30,20252024Stock price$0.30 to $0.75$4.50 to $5.19Exercise price$0.38 to $0.85$4.50 to $5.19Expected volatility96.3% to 103.8%97.06% to